Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F12%3A33143519" target="_blank" >RIV/61989592:15310/12:33143519 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
Original language description
The invention relates to new substituted 6-(2-aminobenzylamino)purines, which can be used in CDK inhibition, in particular, in the treatment of viral infections and diseases involving cell proliferation. The invention further includes pharmaceutical preparations containing substituted 6-(2-aminobenzylamino)purines.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
CC - Organic chemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GA301%2F08%2F1649" target="_blank" >GA301/08/1649: Modulation of cell division of normal and cancer cells by cyclin-dependent kinase inhibitors</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
ZA2011/04945
Publisher
ZA001 -
Publisher name
Companies and Intellectual Property Registration Office (CIPRO)
Place of publication
Pretoria
Publication country
ZA - SOUTH AFRICA
Date of acceptance
Mar 28, 2012
Owner name
Univerzita Palackeho v Olomouci, Bioapex, s.r.o.
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence